Pigmented purpuric dermatosis after BNT162B2 mRNA COVID‐19 vaccine administration
Mehmet Fatih Atak, Banu Farabi, Mehmet Berati Kalelioğlu, Babar Rao
Abstract
Babar K. Rao is a consultant for CaliberID (manufacturer of the VivaScope). Other authors have no conflict of interest to declare. The authors confirm that the data supporting the findings of this study are available within the article.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakAdministration (probate law)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirologyMessenger RNABusinessDermatologyChemistryInternal medicinePolitical scienceBiochemistryGeneLawOutbreakDiseaseInfectious disease (medical specialty)Cutaneous lymphoproliferative disorders researchDermatological and COVID-19 studiesCAR-T cell therapy research